Abstract
The early-response gene product IEX-1 (also known as IER3) was recently found to interact with the anti-apoptotic Bcl-2 family member, myeloid cell leukemia-1 (Mcl-1). In this study we show that this interaction specifically and timely controls the accumulation of Mcl-1 in the nucleus in response to DNA damage. The IEX-1 protein is rapidly induced by γ-irradiation, genotoxic agents or replication inhibitors, in a way dependent on ataxia telangiectasia mutated (ATM) activity and is necessary for Mcl-1 nuclear translocation. Conversely, IEX-1 protein proteasomal degradation triggers the return of Mcl-1 to the cytosol. IEX-1 and Mcl-1 are integral components of the DNA damage response. Loss of IEX-1 or Mcl-1 leads to genomic instability and increased sensitivity to genotoxic and replicative stresses. The two proteins cooperate to maintain Chk1 activation and G2 checkpoint arrest. Mcl-1 nuclear translocation may foster checkpoint and improve the tumor resistance to DNA damage-based cancer therapies. Deciphering the pathways involved in IEX-1 degradation should lead to the discovery of new therapeutic targets to increase sensitivity of tumor cells to chemotherapy.
Similar content being viewed by others
Main
Cells respond to DNA damage by activating a protein network that recognizes the damaged DNA, triggering cell cycle checkpoints, repair of the damaged DNA and/or cell death. The DNA damage response (DDR) is regulated by two primary signaling pathways activated downstream of the effector kinases, ataxia-telangiectasia mutated (ATM) and ATM-and Rad3-related (ATR), which are mutated in ataxia-telangiectasia and Seckel syndrome, respectively. ATM is activated in response to agents inducing DNA double-strand breaks (DSBs), whereas ATR responds to a broad spectrum of genotoxic stresses. In the presence of DSBs, the Mre11/Rad50/Nbs1 complex accumulates at DNA-damage sites, forming subnuclear foci. Recruitment of ATM to this complex fosters its activation, leading to phosphorylation of numerous substrates, including the histone H2AX that serves as a scaffold for the recruitment of DNA repair and checkpoint signaling proteins. ATM triggers the processing of DSBs into extended regions of single-stranded DNA. ATR is then recruited and activated to RPA-coated ssDNA. ATM and ATR phosphorylate the checkpoint kinases Chk1 and Chk2, respectively, which will give cell the time to repair the damaged DNA by arresting their cycle at the G1-S or G2-M transitions and within the S phase.1
In the face of irreparable damage the cell may activate its apoptotic machinery. On the contrary, in response to low levels of damage and during the checkpoint arrests, apoptosis needs to be suppressed to allow repair and avoid unnecessary cell destruction. The correct balance between cell cycle arrest and apoptosis is crucial to ensure genomic stability. This suggests a high and complex interplay between proteins controlling the DDR and the apoptotic pathways. Evolutionary conserved Bcl-2 family members are central regulators of apoptosis. Myeloid cell leukemia-1 (Mcl-1) is an anti-apoptotic member of this family. Models of Mcl-1 knockout mice have shown its requirement for embryonic development and differentiation of various hematopoietic lineages.2, 3, 4 Mcl-1 is regulated at transcriptional, post-transcriptional and post-translational levels.5, 6 Its anti-apoptotic function is regulated by interaction with other Bcl-2 family members.7 Outside of this family, Mcl-1 interacts with proteins regulating apoptosis or cell proliferation, including fortilin, cdk1 and PCNA.8, 9, 10 Recent studies have identified immediate early-response gene X-1 (IEX-1, also known as IER3) as a new partner of Mcl-1.11, 12 IEX-1 is an early-response gene product that is rapidly induced by growth factors, ionizing radiations and viral infections. Conflicting data have been reported concerning its role in survival: IEX-1 was found to not only increase apoptosis in response to TNF-α,11, 13, 14, 15 but also to contribute to growth factor-mediated survival15, 16 and to prevent activation-induced T-cell death.17, 18 Other functions have been attributed to IEX-1 such as regulation of ERK, Akt and NF-κB signaling pathways.14, 16, 19
Unlike a previous report,12 we found that although IEX-1 and Mcl-1 inhibit staurosporin-induced apoptosis, this function is independent of their interaction. A recent study reported that Mcl-1 translocates to the nucleus after treatment with etoposide.20 In this study we show that Mcl-1 nuclear translocation is a general response to genotoxic stress and that it is strictly and timely controlled by IEX-1. IEX-1 expression is rapidly induced by DNA-damaging agents in an ATM-dependent manner and is necessary for Mcl-1 nuclear translocation. Conversely, IEX-1 protein degradation triggers Mcl-1 return to the cytosol. IEX-1 and Mcl-1 are integral components of the DDR pathway. They cooperate to maintain Chk1 activation, and regulate proper G2 checkpoint arrest and repair of DNA lesions and cell survival after treatments with various DNA-damaging agents.
Results
Mcl-1 nuclear accumulation is induced by genotoxic stress and is controlled by IEX-1
Anti-HA antibodies could immunoprecipitate Mcl-1 but not Bcl-2 from cells transfected with HA-IEX-1 and either Myc-Mcl-1 or Flag-Bcl-2 (Figure 1a and Supplementary Figure S1-a). Immunofluorescence (IF) analysis revealed that expression of GFP-IEX-1 induced a striking accumulation of endogenous Mcl-1, but not of Bcl-2 or Bcl-xL, to the nucleus (Figure 1b and Supplementary Figure S1-b). Measurement of mean pixel intensities in the nucleus and in the cytoplasm of random cells showed that Mcl-1, but not Bcl-2 or Bcl-xL, was enriched in the nucleus of the cells overexpressing GFP-IEX-1 (Supplementary Figure S1-c). IEX-1 possesses a nuclear localization signal (NLS) and a putative transmembrane (TM) region.15, 21, 22 Deletion of IEX-1 NLS prevented Mcl-1 nuclear accumulation but not Mcl-1/IEX-1 interaction (Supplementary Figure S1a and b) whereas deletion of IEX-1 TM (IEX-1-ΔTM) abolished both events (Figures 1a and b). Thus, IEX-1-induced Mcl-1 nuclear accumulation is dependent on its interaction with Mcl-1 and requires an intact NLS.
Endogenous IEX-1 expression and Mcl-1 nuclear accumulation were conjointly induced by a variety of DNA-damaging agents such as etoposide, ionizing radiations (IRs) and the replicative inhibitor hydroxyurea (HU) (Figure 1c). IEX-1 could be detected by IF as soon as 30 min after IR (data not shown). The Mcl-1 nuclear/cytoplasmic (N/C) IF intensity ratio was increased in the nucleus of all cells after IR (0.87±0.016 and 1.8±0.06 for non-treated and IR-treated cells, respectively, Supplementary Figure S1-c). Confirming these results, cell fractionation indicated that the nucleus of resting cells contains 15% (N/C ratio of 0.18) of total Mcl-1, whereas this level reached up to 40% (N/C ratio of 0.8) after IR or HU (Figure 1d). Neither IEX-1 overexpression nor DNA damage had any effect on total Mcl-1 levels or half-life (Figure 1d and Supplementary Figure S1-d).
Endogenous IEX-1 and Mcl-1 colocalized in the nucleus and could be co-immunoprecipitated from the nuclear fraction of HeLa cells after HU or IR treatments (Figures 1c and e). IF analysis in cells subjected to detergent extraction before fixation showed that although the global intensity of the signal was greatly decreased under these conditions, most of the IR-treated cells stained positively for nuclear Mcl-1 and IEX-1 (Figure 1f). In contrast, the Mcl-1 signal was entirely lost in non-treated cells. This further supports Mcl-1 delocalization upon IR and indicates that IEX-1 and Mcl-1 associate, at least partially, with the chromatin fraction after DNA damage.
HeLa cells expressing IEX-1 short hairpin RNAs (shRNAs)23 showed a great decrease in both IEX-1 induction and Mcl-1 nuclear accumulation upon HU or IR treatment (Figures 2a and b). Fractionation experiments showed that IR increased Mcl-1 levels in the nuclear fraction of cells expressing scramble but not IEX-1 shRNAs (Figure 2c). Moreover, although in IEX-1+/+ hematopoietic progenitors Mcl-1 had entirely moved from the cytoplasm to the nucleus 3 h after IR, its localization remained unchanged in IEX-1−/− cells (Figure 2d). Expression of IEX-1 in IEX-1−/− mouse embryonic fibroblasts (MEFs) restored IR-mediated Mcl-1 nuclear staining (Supplementary Figure S2). Thus, IEX-1 induction is a prerequisite for IR-induced Mcl-1 nuclear translocation.
ATM activity is required for IEX-1 expression and to maintain Mcl-1 in the nucleus
Both IR- or HU-mediated IEX-1 expression and Mcl-1 nuclear accumulation were abolished in ATM-deficient GM3189 lymphoblastoid cells and upon treatment of HeLa cells with the ATM inhibitors caffeine and KU-55933 (Figures 3a and b), showing that these events require ATM activity.
IEX-1 is a short half-life protein, sensitive to degradation by the proteasome. In cells treated overnight with HU and then released in HU-free medium, IEX-1 staining was strong at 5 h, started to fade at 9 h and disappeared at 16 h (Figure 3c). Mcl-1 localized to the nucleus as long as IEX-1 was present and returned to the cytosol when IEX-1 vanished. Addition of the proteasome inhibitor, N-acetyl-Leu-Leu-NorLeu-al (LLnL), at 5 h prevented IEX-1 disappearance and Mcl-1 nuclear exit. In the absence of HU, treatment with LLnL alone for 4 h did not induce IEX-1. In agreement with previous reports,5, 6 Mcl-1 expression increased slightly under these conditions but it remained mostly located in the cytoplasm. No apoptosis could be detected up to 16 h, showing that neither the nuclear localization of Mcl-1 nor its relocalization to the cytosol is linked to cell death. Thus, IEX-1 is necessary to both bring and maintain Mcl-1 into the nucleus.
To determine whether ATM activity is required to maintain IEX-1 expression once induced, the cells were synchronized, arrested in G2 by IR and then treated with caffeine or KU-55933.24 Inhibition of ATM activity accelerated IEX-1 degradation and triggered Mcl-1 nuclear exit (Figure 3d), showing that IEX-1 induction and degradation, as well as the subsequent nucleo-cytoplasmic movement of Mcl-1, are DNA damage- and ATM-controlled events.
Mcl-1-deficient cells show prolonged DNA damage and impaired DNA repair
To assess the role of Mcl-1 in the DDR, we first monitored the extent of DNA damage by analyzing the presence of γ-H2AX foci. At 30 min after HU treatment, most Mcl-1+/+ and Mcl-1−/− MEFs presented γ-H2AX foci. However, γ-H2AX staining declined more rapidly in wild-type (WT) than in Mcl-1−/− cells (Figure 4a and Supplementary Figure S3-a). Mcl-1−/− MEFs regained normal γ-H2AX foci disappearance kinetics upon infection with a Mcl-1-encoding but not with an empty vector. The slower removal of γ-H2AX foci, indicative of prolonged DNA damage, was also found after irradiation of shMcl-1-expressing HeLa cells (Supplementary Figure S3-b).
Persistent DNA damage may result from defects in DNA repair, cell cycle checkpoints or both. To analyze the first possibility, we performed comet assays. DNA breaks are visible by increased DNA mobility or ‘comet tails’. The comet tail moment was measured to quantify the extent of unrepaired DNA. Just after irradiation, all the cells showed comparable amounts of DNA breaks. However, 1 h later, Mcl-1+/+ MEFs had rejoined 74% of the breaks, whereas 63% of them remained unrepaired in Mcl-1−/− cells. This defect was completely restored upon re-expression of Mcl-1 in Mcl-1−/− cells (Figure 4b). Interestingly, non-treated-Mcl-1−/− cells had a basal tail moment slightly but reproducibly higher than control cells, showing that they contain unresolved DNA damage. This suggests that Mcl-1 could have a role in the repair of both induced and spontaneous DNA damage occurring during normal DNA replication.
Mcl-1 deficiency leads to impaired Chk1 phosphorylation and G2/M arrest
To get insights into the mechanisms by which Mcl-1 influences the DDR, we examined whether its expression affected DNA damage signaling. ATM phosphorylation was not decreased but was rather more pronounced in shMcl-1-expressing HeLa cells (Figure 5a). The loss of Mcl-1 led to a decreased IR-induced Chk1 phosphorylation on serines 296, 345 and 317, the three sites targeted by ATR (Figures 5a and b). This effect was particularly striking at longer time points, suggesting that Mcl-1 is not required to activate Chk1 but to maintain its activity. No decrease in the phosphorylation of the other ATM/ATR substrates, Chk2, RPA32, Rad17, SMC1 and NBS1, could be observed. The prolonged phosphorylation of H2AX confirmed the sustained presence of γ-H2AX foci in Mcl-1-deficient cells. These data suggest that Mcl-1 contributes to DDR by maintaining selectively Chk1 activation.
Chk1 is required for intra-S and G2/M checkpoint activation. To analyze both phases of the cell cycle, the cells were doubly labeled with BrdU and propidium iodide (PI). Inhibition of Mcl-1 expression had no effect on the unperturbed cell cycle (Figure 5c). IR induced accumulation of control cells in the S and G2 phases of the cell cycle. Mcl-1 downregulation had no effect on the S-phase progression or on the accumulation in G2 until 6 h after IR. However, at 24 h after IR, although control cells were still blocked in G2, shMcl-1-expressing cells had already started to re-enter in G1. A similar shorter G2 arrest was observed in Mcl-1-deficient MEFs (Supplementary Figure S3-c). Thus, Mcl-1 is indispensable to maintain Chk1 phosphorylation and the G2 checkpoint, allowing correct DNA repair in response to DNA damage.
IEX-1- and Mcl-1 act on the same pathway to regulate the DDR
HeLa cells expressing IEX-1-shRNA, as well as IEX-1−/− MEFs, showed spontaneous DNA breakage and, after IR, sustained γ-H2AX staining, delayed repair of DSBs (Figure 6a and Supplementary Figure S4-a), reduced length of the G2/M arrest (Figure 6b) and decreased Chk1 phosphorylation (Figure 6c and Supplementary Figure S4-b). Infection of IEX-1−/− MEFs with IEX-1-encoding vector rescued completely the kinetics of γ-H2AX foci removal and of DNA repair in response to IR (Figure 6a and Supplementary Figure S4-a). Thus, IEX-1 deficiency recapitulates Mcl-1 deficiency, suggesting that the two proteins act on the same pathway in the DDR. In agreement with this hypothesis, IEX-1−/− cells expressing the IEX-1-ΔTM mutant, which fails to interact with Mcl-1, behaved as IEX-1−/− cells transfected with GFP (Figure 6a and Supplementary Figure S4-a). Moreover, expression of IEX-1 could rescue the kinetics of disappearance of γ-H2AX foci in HeLa cells expressing shIEX-1 but not in cells expressing shIEX-1 and shMcl-1 together (Figure 6d). This shows that the ability of IEX-1 to affect the DDR requires association with Mcl-1 and its translocation to the nucleus.
We then determined the region of Mcl-1 involved in IEX-1 binding. Truncation of the C-terminal 20 amino-acids of Mcl-1 (ΔCter), encoding the transmembrane region, abolished its interaction with IEX-1 (Figure 7a). Mcl-1 WT, but not ΔCter, could fully restore DNA repair as well as Chk1 phosphorylation in Mcl-1−/− MEFs (Figures 7b and c). However, Mcl-1 WT was unable to restore the rapid disappearance of γ-H2AX foci of Mcl-1−/− MEFs in which IEX-1 expression had been knocked down by IEX-1 shRNAs (Figure 7d). Altogether, these results show that IEX-1 and Mcl-1 require each other and act on a unique pathway to regulate the DDR.
IEX-1- or Mcl-1-deficient cells show genomic instability
Mcl-1−/− MEFs and IEX-1−/− progenitors showed increased sensitivity to IR, relative to their WT counterparts (Figures 8a and b). After IR or HU, up to 62% of shIEX-1- and shMcl-1-expressing cells presented micro or fragmented nuclei, which could be easily distinguished from apoptotic cells (Figure 8c). Spontaneous micronuclei were also observed at a frequency slightly higher (1.4- to 2-fold) in these cells than in shControl-expressing cells. Other abnormalities, indicative of increased genomic instability, such as nuclear blebbing, multinucleation or unequal division, were also observed in the absence of IEX-1 or Mcl-1.
IEX-1-deficient mice also showed genomic instability. At 1 month after whole-body irradiation, metaphase spreads of cells isolated from IEX-1−/− bone marrows and spleens showed a significant increase in chromosomal aberrations when compared with controls (Figure 8d). Thus, the absence of IEX-1 leads to sustained DNA lesions in hematopoietic cells. However, no difference in survival between WT and IEX-1−/− mice was observed at that time, suggesting that compensatory mechanisms would limit the effect of this defect on irradiated organisms.
Discussion
Cell cycle arrest, survival and DNA repair are coordinately controlled in the face of DNA damage. Recent data have revealed the existence of unexpected direct interactions between checkpoint/repair components and members of the Bcl-2 family or other regulators of the apoptotic pathway. For example, Bid and APAF translocate to the nucleus and affect S-phase arrest after DNA damage,25, 26, 27 and Bax and Bcl-2 negatively regulate homologous recombination.28 In this study we show that Mcl-1 is an integral component of the DDR, in multiple types of primary and transformed cells, and in response to various stresses such as IR, genotoxic agents or replication inhibitors. Cells lacking Mcl-1 show altered G2 checkpoint, leading to extended DNA damage and inefficient DNA repair. These defects translate into increased genomic instability and sensitivity in response to DNA damage.
DNA damage triggers a striking accumulation of Mcl-1 in the nucleus and its association with the chromatin. The signal regulating Bid function in DNA damage is provided by ATM phosphorylation.25, 27 The Mcl-1 protein sequence does not present ATM/ATR phosphorylation sites. We show that Mcl-1 nuclear accumulation and function upon DNA damage occurs in an ATM-dependent manner through a new mechanism involving its association with IEX-1. Indeed, (1) IEX-1 binds to Mcl-1 and triggers its nuclear accumulation; (2) Mcl-1 nuclear accumulation and induction of IEX-1 by DNA-damaging agents are concomitant and dependent on ATM activity; (3) DNA damage-induced Mcl-1 nuclear accumulation is blunted in IEX-1-deficient cells; and (4) IEX-1 and Mcl-1 are functionally interdependent, as IEX-1 or Mcl-1 expression cannot restore the DDR in a double IEX-1- and Mcl-1-deficient background. IEX-1 loss can fully reproduce the defects in G2 arrest and DNA repair of Mcl-1-deficient cells. Bone marrows and spleens of IEX-1−/− mice also presented signs of genomic instability 1 month after whole-body irradiation, showing that impeding Mcl-1 nuclear accumulation is biologically significant. IEX-1 serves as a signal for Mcl-1 nuclear entry and as an anchor to maintain it in the nucleus during the DDR. Indeed, Mcl-1 relocalization to the cytoplasm is concomitant to IEX-1 disappearance and is prevented upon inhibition of IEX-1 degradation. Interestingly, IEX-1 degradation and Mcl-1 nuclear exit precede cell recovery from G2 arrest and re-entry into mitosis (Supplementary Figure S5-a). Silencing of checkpoint signaling, by adding ATM inhibitors after the cells were arrested in G2, accelerates IEX-1 degradation and Mcl-1 nuclear exit (Figure 3d), together with re-entry in mitosis (Supplementary Figure S5-b). Thus, both IEX-1 induction and degradation are DNA damage-sensed and ATM-dependent events. They represent a sensitive means to timely and specifically control the presence of Mcl-1 in the nucleus after DNA damage, allowing maintenance of the G2 arrest and its subsequent switch-off, authorizing the re-entry into the cell cycle.
Previous reports have shown that DNA damage can trigger a rapid decrease in Mcl-1 protein and/or mRNA levels, whereas others have reported the opposite results.5, 20, 29 These discrepancies may be linked to the types of detergent used to prepare the lysates, as we show that Mcl-1 partially associates with chromatin after DNA damage and/or with the doses of DNA-damaging agents. We did not observe major change in Mcl-1 levels, upon DNA damage, overexpression or downregulation of IEX-1, indicating that IEX-1 alters only Mcl-1 subcellular localization. IEX-1, as Mcl-1, associates with mitochondria and endoplasmic reticulum membranes.15, 16 IEX-1/Mcl-1 interaction requires their transmembrane domains. Thus, IEX-1 could bind to Mcl-1 in the mitochondrial membrane and then transport it to the nucleus. Supporting this possibility, IEX-1-ΔNLS was unable to induce Mcl-1 nuclear accumulation and the two proteins co-precipitated from both nuclear and cytosolic fractions. On the other hand, Mcl-1 is present at low levels in the nucleus in the absence of genotoxic stress.8, 9, 10 Thus, although IEX-1 appears as a major mechanism controlling Mcl-1 nuclear accumulation upon DNA damage, Mcl-1 may transit to the nucleus independently of IEX-1 during the normal cell cycle. This result fits with previous reports showing that overexpression of Mcl-1 inhibits cell cycle progression in the absence of DNA damage.9, 10
The slow decrease in the comet tail moments in IEX-1- or in Mcl-1-depleted cells after irradiation suggests that these cells accumulate DSBs because of defects in DNA repair. However, their cell cycle arrest was not longer. In fact the opposite is observed. This suggests that IEX-1/Mcl-1 complexes have a major role in checkpoint signaling, at the level or downstream of the activation of the checkpoint kinases. Indeed, Chk1 activation was selectively impaired in the absence of IEX-1 or Mcl-1. This defect can explain why these cells accumulate DSBs;30 however, how IEX-1 and Mcl-1 cooperate to maintain Chk1 activation is unknown. After IR, several proteins required for the DDR accumulate to chromatin in discrete foci, which are needed for activation of Chk1/Chk2.1 Although Mcl-1 and IEX-1 partially associate with chromatin, they do not seem to participate to the recruitment of DDR proteins to foci. Indeed, soon after IR, γ-H2AX was normally enriched in foci in Mcl-1 or IEX-1-deficient cells. This is consistent with the fact that IEX-1 expression and Mcl-1 nuclear accumulation could be detected only approximately 30 min after IR. Neither the phosphorylation of ATM and its substrates (NBS1, SMC1 and Chk2) nor that of the ATR substrates (RPA and Rad17) required for Chk1 activation30 was compromised in the absence of Mcl-1, suggesting that IEX-1/Mcl-1 complexes affect signaling downstream of ATM/ATR activation. Jamil et al.20 have reported that etoposide induces a truncated form of Mcl-1 that associates with Chk1, but we were unable to reproduce these results. This might be because of the different antibodies or lysates conditions used. Claspin binds to Chk1 and ATR and is essential for Chk1 phosphorylation.31 However, we could not precipitate Mcl-1 or IEX-1 with claspin. Claspin and Chk1 levels were not decreased in Mcl-1-deficient cells, showing that their degradation was not affected.32, 33, 34 On the other hand, IEX-1 mutants, which were impaired in their ability to inhibit PP2A,23 could restore the DDR of IEX-1−/− MEFs (data not shown), suggesting that IEX-1/Mcl-1 do not maintain Chk1 activity by inhibiting its dephosphorylation by these phosphatases.35
In contrast with the apoptosis ensuing Mcl-1 mitochondrial degradation,5 the delocalization of Mcl-1 to the nucleus upon DNA damage triggers DNA repair and checkpoint survival signals. IEX-1 depletion increases cell radiosensitivity while leaving intact the Mcl-1- mitochondrial pool. Thus, Mcl-1 function in the DDR requires its nuclear localization and is separately controlled from its activity at the mitochondria. Mcl-1 is overexpressed in many tumors and it is often responsible for the resistance to treatment with the BH3-mimetic ABT-737.36 Cancer therapies involving DNA-damaging agents have the potential to induce IEX-1 expression and Mcl-1 nuclear localization, in which they may act together to foster checkpoint and improve the tumor resistance to DNA damage. Deciphering the pathways involved in IEX-1 degradation should lead to the discovery of new therapeutic targets to increase tumor cells sensitivity to chemotherapy.
Materials and Methods
Chemicals and antibodies
Hydroxyurea, the proteasome inhibitor LLnL, etoposide, caffeine, cytochalasin B and colcemid were purchased from Sigma Aldrich (Saint Louis, MO, USA). Ku-55933 was from Calbiochem (Darmstadt, Germany). The antibodies used were as follows: rabbit serum anti-IEX-1 was described previously;16 anti-phospho antibodies to Chk1 (Ser345, Ser317 and Ser296), Chk2, ATM, NBS1, Rad17 and rabbit polyclonal anti-γ-H2AX (Cell Signaling Technology, Inc., Danvers, MA, USA); anti-pSer10-Histone H3, mouse monoclonal anti-γH2AX and anti-GFP (Millipore, Billerica, MA, USA); anti-pRPA32 and anti-pSMC1 (Bethyl Labs, Montgomery, TX, USA); anti-Mcl-1 (S19), anti-ERK1 (K23), rabbit anti-Chk1 (Fl-476) and goat anti-IEX-1 (C20) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA); anti-HA (3F10 and 12CA5) and anti-Myc (9E10) (Roche Applied Science, Meylan, France); anti-RAD51 (Calbiochem); anti-actin (C40), anti-Flag (M2) and monoclonal anti-Chk1 (DCS-310) (Sigma Aldrich). Fluorochrome-conjugated antibodies, anti-rabbit AlexaFluor 594 and 647; anti-mouse AlexaFluor 405 (Invitrogen, Carlsbad, CA, USA) and FITC anti-goat; FITC anti-mouse and Rhodamine anti-goat (Jackson Immunoresearch, West Grove, PA, USA).
Cells and mice
IEX-1−/− and WT littermates mice on the mixed 129/Sv × C57BL/6 background37 were imported from the Mayo Clinic (Rochester, MN, USA) and housed in a specific pathogen-free environment. The experiments were conducted following standard ethical guidelines. Primary MEFs were obtained from IEX-1−/− and IEX-1+/+ embryos at day 12 p.c. and resuspended in DMEM supplemented with 10% fetal calf serum (FCS), 1% non-essential amino acids (NEAA, Invitrogen), 1% L-glutamine and 1% penicillin/streptomycin (PS). To obtain lineage-negative (Lin−) hematopoietic progenitors, bone marrow cells from 1- to 3-month-old mice were harvested from tibiae and femurs and depleted of lineage-positive cells using the Biotin-conjugated Mouse Lineage Panel of antibodies and magnetic beads (BD Pharmingen, San Jose, CA, USA). Immortalized WT and Mcl-1−/− MEFs2 were a generous gift from JT Opferman (St. Jude Children's Research Hospital, Memphis TN, USA). Cells were cultured in DMEM supplemented with 10% FCS, 1% NEAA, 1% L-glutamine, 1% PS and 0.1 μM β-mercaptoethanol. Chinese hamster ovary (CHO) and HeLa cells were cultured in Dulbecco's MEM Mix F-12 and DMEM, respectively, supplemented with 10% FCS. ATM WT (HSC93) and ATM-null (AT GM3189) human lymphoblasts were grown in RPMI medium with 12% FCS. All irradiation experiments were carried out using a Biobeam 8000 irradiator (Gamma Service Medical GmbH, Leipzig, Germany). All commercially available cell lines were from the American Type Culture Collection (ATCC, Manassas, VA, USA).
Plasmids, infections and transfections
IEX-1 constructs were described previously.16, 23 pcDNA-HA-IEX-1 deleted of its transmembrane domain (IEX-1-ΔTM) was generated by removing amino acids 86–101,21 using QuickChange site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). IEX-1 WT and ΔTM were subcloned in pTRIPΔU3-EF1α-IRES-GFP38 or in pRetro-x-IRES-DsRed (Clontech, Mountain View, CA, USA) lentiviral and retroviral vectors, respectively. pTRIPΔU3-EF1α-GFP encoding shRNAs against IEX-1 or controls (shScramble or shGFP) were previously described.38 The vector encoding shRNA for murine IEX-1 was constructed as above using 5′-CATTGCCAAGAGGGTCCTC-3′ (nucleotides 243–261) as the target sequence. pLL3.7 lentiviral constructs encoding three different shRNAs for Mcl-1 and GFP39 were gifts from A Nencioni (MIT, Cambridge, MA, USA). Myc-Mcl-1 was provided by M-C Hung (University of Texas, MD Anderson Cancer Center, Houston, TX, USA). Myc-Mcl-1-ΔCter was made by deletion of amino acids 330–350 by adding a stop codon by PCR amplification. Myc-Mcl-1 WT and ΔCter cDNAs were then subcloned into pRetro-x-IRES-DsRed. Transient transfection of CHO and HeLa cells were performed with Lipofectamine (Invitrogen), as described.23 Production and titration of retroviral and lentiviral particles and infections were performed as described.38 The infection efficiency was assayed by testing DsRed or GFP expression using flow cytometry.
Immunoprecipitation and subcellular fractionation
Immunoprecipitation procedures were described previously.23 For subcellular fractionation, cells were lysed in 10 mM HEPES, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, 1 mM DTT, 10 mM NaF, 1 mM Na2VO3, 0.1% Triton X-100 and Roche protease inhibitor cocktail for 5 min at 4°C. After centrifugation (4 min, 1300 × g, 4 °C), the nuclear pellet was resuspended in 50 mM Tris pH 7.5, 137 mM NaCl, 0.5% NP-40, 10% glycerol, 1 mM EDTA, 1 mM Na2VO3, 20 mM NaF and 1 mM sodium pyrophosphate.
Immunofluorescence
Cells grown on glass coverslips were fixed with 3.7% paraformaldehyde (15 min at room temperature (RT)), washed with PBS and permeabilized with ice-cold methanol followed by incubation in blocking buffer (10% horse serum, 1% BSA for γ-H2AX and Mcl-1 or 0.3% BSA, 0.2% glycine for IEX-1) for 1 h at RT and with primary antibodies (in PBS with 0.1% Triton X-100) overnight in 4°C. Fluorescent-conjugated secondary antibody was then added for 1 h at RT. Nuclei were counterstained with DAPI. To detect chromatin-bound proteins, soluble proteins were pre-extracted with detergent before fixation: the cells were washed and incubated for 1 min at RT in 60 mM PIPES, 25 mM HEPES-KOH, pH 6.9, 10 mM EGTA, 2 mM MgCl2 and 0.5% Triton X-100 and then fixed with ice-cold methanol for 5 min at −20°C, before staining, as above. All slides were visualized using Leica DMI 6000 microscope (Wetzlar, Germany) equipped with a 63 × 1.6 oil-immersion objective and a MicroMAX 1300Y camera (Princeton Instruments, Trenton, NJ, USA). Pictures were analyzed using ImageJ software (developed at the National Institute of Health, Bethesda, MD, USA).
Comet assay
Cells were mock-treated or irradiated at 10 Gy and were either transferred directly on ice or allowed to recover at 37°C for 1 h. Neutral comet assay was performed using the CometAssay kit (Trevigen Inc., Gaithersburg, MD, USA). After drying, slides were stained with Hoechst 33342 and comet tails were visualized by a fluorescent microscope Leica DMI 6000 and analyzed using TriTek CometScore software (Tritek Corp., Sumerduck, VA, USA).
Survival assay
For clonogenic survival assays, MEFs were irradiated with various doses, transferred to 10 cm diameter dishes and allowed to grow for 6 days (MEFs). The cells were then fixed with ice-cold methanol and stained with 0.5% Giemsa solution. Colonies containing >50 cells were scored. Apoptosis of Lin− progenitors was evaluated by measuring SubG1 DNA contents 16 h after IR, using Cytomix TM FC500, Beckman Coulter flow cytometer (Beckman Coulter France, Villepinte, France).
Genomic instability
Genomic instability in vitro was assessed by micronuclei appearance. Cells were incubated with cytochalasin B (2 μg/ml) for 24 h. After fixation and DNA staining with DAPI, binuclear cells were scored for micronuclei. To evaluate chromosomal aberrations after whole-body irradiation, IEX-1−/− and age-matched control mice were exposed to IR (7 Gy). After 1 month, the mice were killed and bone marrow and spleen cell suspensions were prepared. Bone marrow cells were cultured in DMEM supplemented with 10% FCS. Splenocytes were resuspended in RPMI containing 12% FCS and concanavalin A (5 μg/ml). After 48 h, the cells were incubated in the presence of colcemid for 3 h, fixed, and metaphase spreads were prepared, as described.40 At least 30 metaphases from each sample were scored for the presence of deletions, fusions and triradial chromatid chromosomal aberrations.
BrdU labeling and cell cycle analysis
30 min before test time points, the cells were pulsed labeled with 30 μM BrdU (Invitrogen), washed and fixed in 70% ethanol. Staining with anti-BrdU antibody and PI was described previously26 Samples were analyzed by flow cytometry using CellQuest software (BD Biosciences, le Pont de Claix, France).
Statistical analysis
Results were statistically evaluated using two-way ANOVA and Bonferroni comparison post-test or t-test using GraphPad PrismTM version 4.0 software (GraphPad Software Inc., San Diego, CA, USA). Results are shown as means±S.E.M. and the value of *P<0.05 was determined as significant, and of **P<0.01 or ***P<0.001 as highly significant.
Abbreviations
- IEX-1:
-
immediate early-response gene X-1
- Mcl-1:
-
myeloid cell leukemia-1
- ATM:
-
ataxia-telangiectasia mutated
- ATR:
-
ATM-and Rad3-related
- DDR:
-
DNA damage response
- DSB:
-
double strand break
- IR:
-
ionizing radiation
- HU:
-
hydroxyurea
- LLnL:
-
N-acetyl-Leu-Leu-NorLeu-al
- PI:
-
propidium iodide
- IF:
-
immunofluorescence
- N/C:
-
nuclear/cytoplasmic
- MEF:
-
mouse embryonic fibroblast
- WT:
-
wild type
- Lin–:
-
lineage-negative bone marrow cell
- TM:
-
transmembrane region
- NLS:
-
nuclear localization signal
- shRNA:
-
short hairpin RNA
- CHO:
-
Chinese hamster ovary
- FCS:
-
fetal calf serum
- NEAA:
-
non-essential amino acid
- PS:
-
penicillin/streptomycin
- RT:
-
room temperature
References
Bartek J, Lukas J . DNA damage checkpoints: from initiation to recovery or adaptation. Curr Opin Cell Biol 2007; 19: 238–245.
Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ . Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003; 426: 671–676.
Opferman JT, Iwasaki H, Ong CC, Suh H, Mizuno S, Akashi K et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005; 307: 1101–1104.
Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ . Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev 2000; 14: 23–27.
Nijhawan D, Fang M, Traer E, Zhong Q, Gao W, Du F et al. Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 2003; 17: 1475–1486.
Yang T, Kozopas KM, Craig RW . The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol 1995; 128: 1173–1184.
Cory S, Huang DC, Adams JM . The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 2003; 22: 8590–8607.
Zhang D, Li F, Weidner D, Mnjoyan ZH, Fujise K . Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone. J Biol Chem 2002; 277: 37430–37438.
Fujise K, Zhang D, Liu J, Yeh ET . Regulation of apoptosis and cell cycle progression by MCL1. Differential role of proliferating cell nuclear antigen. J Biol Chem 2000; 275: 39458–39465.
Jamil S, Sobouti R, Hojabrpour P, Raj M, Kast J, Duronio V . A proteolytic fragment of Mcl-1 exhibits nuclear localization and regulates cell growth by interaction with Cdk1. Biochem J 2005; 387: 659–667.
Kumar R, Lutz W, Frank E, Im HJ . Immediate early gene X-1 interacts with proteins that modulate apoptosis. Biochem Biophys Res Commun 2004; 323: 1293–1298.
Yoon S, Ha HJ, Kim YH, Won M, Park M, Ko JJ et al. IEX-1-induced cell death requires BIM and is modulated by MCL-1. Biochem Biophys Res Commun 2009; 382: 400–404.
Arlt A, Grobe O, Sieke A, Kruse ML, Folsch UR, Schmidt WE et al. Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells. Oncogene 2001; 20: 69–76.
Arlt A, Rosenstiel P, Kruse ML, Grohmann F, Minkenberg J, Perkins ND et al. IEX-1 directly interferes with RelA/p65 dependent transactivation and regulation of apoptosis. Biochim Biophys Acta 2008; 1783: 941–952.
Shen L, Guo J, Santos-Berrios C, Wu MX . Distinct domains for anti- and pro-apoptotic activities of IEX-1. J Biol Chem 2006; 281: 15304–15311.
Garcia J, Ye Y, Arranz V, Letourneux C, Pezeron G, Porteu F . IEX-1: a new ERK substrate involved in both ERK survival activity and ERK activation. EMBO J 2002; 21: 5151–5163.
Mittal A, Papa S, Franzoso G, Sen R . NF-kappaB-dependent regulation of the timing of activation-induced cell death of T lymphocytes. J Immunol 2006; 176: 2183–2189.
Zhang Y, Schlossman SF, Edwards RA, Ou CN, Gu J, Wu MX . Impaired apoptosis, extended duration of immune responses, and a lupus- like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci USA 2002; 99: 878–883.
Rocher G, Letourneux C, Lenormand P, Porteu F . Inhibition of B56-containing protein phosphatase 2As by the early response gene IEX-1 leads to control of Akt activity. J Biol Chem 2007; 282: 5468–5477.
Jamil S, Mojtabavi S, Hojabrpour P, Cheah S, Duronio V . An essential role for MCL-1 in ATR-mediated CHK1 phosphorylation. Mol Biol Cell 2008; 19: 3212–3220.
Kondratyev AD, Chung KN, Jung MO . Identification and characterization of a radiation-inducible glycosylated human early-response gene. Cancer Res 1996; 56: 1498–1502.
Kruse ML, Arlt A, Sieke A, Grohmann F, Grossmann M, Minkenberg J et al. Immediate early gene X1 (IEX-1) is organized in subnuclear structures and partially co-localizes with promyelocytic leukemia protein in HeLa cells. J Biol Chem 2005; 280: 24849–24856.
Letourneux C, Rocher G, Porteu F . B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK. EMBO J 2006; 25: 727–738.
van Vugt MA, Bras A, Medema RH . Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. Mol Cell 2004; 15: 799–811.
Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005; 122: 593–603.
Zermati Y, Mouhamad S, Stergiou L, Besse B, Galluzzi L, Boehrer S et al. Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell 2007; 28: 624–637.
Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ . A role for proapoptotic BID in the DNA-damage response. Cell 2005; 122: 579–591.
Dumay A, Laulier C, Bertrand P, Saintigny Y, Lebrun F, Vayssiere JL et al. Bax and Bid, two proapoptotic Bcl-2 family members, inhibit homologous recombination, independently of apoptosis regulation. Oncogene 2006; 25: 3196–3205.
Zhan Q, Bieszczad CK, Bae I, Fornace Jr AJ, Craig RW . Induction of BCL2 family member MCL1 as an early response to DNA damage. Oncogene 1997; 14: 1031–1039.
Chen Y, Sanchez Y . Chk1 in the DNA damage response: conserved roles from yeasts to mammals. DNA Repair (Amst) 2004; 3: 1025–1032.
Lee J, Kumagai A, Dunphy WG . Claspin, a Chk1-regulatory protein, monitors DNA replication on chromatin independently of RPA, ATR, and Rad17. Mol Cell 2003; 11: 329–340.
Mailand N, Bekker-Jensen S, Bartek J, Lukas J . Destruction of claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol Cell 2006; 23: 307–318.
Peschiaroli A, Dorrello NV, Guardavaccaro D, Venere M, Halazonetis T, Sherman NE et al. SCFbetaTrCP-mediated degradation of claspin regulates recovery from the DNA replication checkpoint response. Mol Cell 2006; 23: 319–329.
Zhang YW, Otterness DM, Chiang GG, Xie W, Liu YC, Mercurio F et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell 2005; 19: 607–618.
Leung-Pineda V, Ryan CE, Piwnica-Worms H . Phosphorylation of Chk1 by ATR is antagonized by a Chk1-regulated protein phosphatase 2A circuit. Mol Cell Biol 2006; 26: 7529–7538.
van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006; 10: 389–399.
Sommer SL, Berndt TJ, Frank E, Patel JB, Redfield MM, Dong X et al. Elevated blood pressure and cardiac hypertrophy after ablation of the gly96/IEX-1 gene. J Appl Physiol 2006; 100: 707–716.
Hamelin V, Letourneux C, Romeo PH, Porteu F, Gaudry M . Thrombopoietin regulates IEX-1 gene expression through ERK-induced AML1 phosphorylation. Blood 2006; 107: 3106–3113.
Nencioni A, Hua F, Dillon CP, Yokoo R, Scheiermann C, Cardone MH et al. Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosis. Blood 2005; 105: 3255–3262.
Naim V, Rosselli F . The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat Cell Biol 2009; 11: 761–768.
Acknowledgements
We thank Drs. JF Opferman for the generous gift of Mcl-1−/− MEFs, A Nencioni for pLL3.7 encoding Mcl-1-specific shRNAs and M-H Hung for Myc-Mcl-1 construct. This work was supported by grants from Association for International Cancer Research (AICR, 07-0065), Association pour la Recherche sur le Cancer (A06/1/4012), Ligue Contre le Cancer (RS08/75-28) and Fondation de France (2006008194). PP and IL were supported by fellowships from Fondation pour le Recherche Médicale, DIM STEM-Pôle and from AICR, respectively.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by A Villunger
Supplementary Information accompanies the paper on Cell Death and Differentiation website
Supplementary information
Rights and permissions
About this article
Cite this article
Pawlikowska, P., Leray, I., de Laval, B. et al. ATM-dependent expression of IEX-1 controls nuclear accumulation of Mcl-1 and the DNA damage response. Cell Death Differ 17, 1739–1750 (2010). https://doi.org/10.1038/cdd.2010.56
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cdd.2010.56
Keywords
This article is cited by
-
N6-Methyladenosine Methylation of mRNA in Cell Apoptosis
Molecular Neurobiology (2023)
-
MCL1 nuclear translocation induces chemoresistance in colorectal carcinoma
Cell Death & Disease (2022)
-
MCL1 alternative polyadenylation is essential for cell survival and mitochondria morphology
Cellular and Molecular Life Sciences (2022)
-
The multiple mechanisms of MCL1 in the regulation of cell fate
Communications Biology (2021)
-
MCL1 binding to the reverse BH3 motif of P18INK4C couples cell survival to cell proliferation
Cell Death & Disease (2020)